Purpose There is suspicion for increasing incidence of necrotising soft tissue infections (NSTIs) during COVID-19 era compared to pre-COVID-19 era. We aim to investigate correlative factors, comparing patient variables and risk factors between the two cohorts to provide more details on the perceived increased NSTI incidence during COVID-19 era. Methodology We retrospectively investigated all patients who presented with NSTI to two NSW hospitals from January 2014 to January 2023. Patient medical records were reviewed with outcomes collected and statistically analysed on Stata® using Wilcoxon rank sum tests, chi-square tests, Fisher’s exact tests and two-sample Wilcoxon rank-sum test. Results Sixty-nine patients underwent debridement for NSTI across both cohorts. Thirty-six were males, 41 patients in pre-COVID era and 28 in COVID era. Median age was 57 years (range 14-95). Average NSTI cases pre-COVID was 6.65 per year (range 3-11) compared to post-COVID average of 9.6 per year (range 2-18). Total NSTI frequency reduced during the lockdown period 2020-21 (n=8) but rose significantly in 2022 (n=18). Correct diagnosis of NSTI in COVID era was 3.7 times more likely compared to pre-COVID era (p=0.011). Mean time to presentation from symptom onset was 5.12 (±4.79) days in pre-COVID population compared to 7.56 (±4.92) days in COVID (p=0.0082) revealing increased delay to medical care by patients in COVID-era. Conclusion Increased presentation of NSTI during COVID era are likely a progression of soft tissue infections due to delayed patient presentation due to fears of contracting COVID-19 as reported however larger cohort studies are required for further analyses.